Table 2 Cell growth inhibition values (μM).

From: Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity

 

Cisplatin

RAED-C

RAPTA-C

A2780

 IC50

1.00±0.05

4.53±0.93

247±15

 IC90

9.17±1.85

17.6±1.2

772±35

crA2780

 IC50

14.0±0.3

6.8±0.3

507±38

 IC90

26.4±0.6

17.9±0.3

933±58

  1. Mean±s.d., n=3.